169 related articles for article (PubMed ID: 37862171)
1. An essential role for miR-15/16 in Treg suppression and restriction of proliferation.
Johansson K; Gagnon JD; Zhou SK; Fassett MS; Schroeder AW; Kageyama R; Bautista RA; Pham H; Woodruff PG; Ansel KM
Cell Rep; 2023 Oct; 42(10):113298. PubMed ID: 37862171
[TBL] [Abstract][Full Text] [Related]
2. An essential role for miR-15/16 in Treg suppression and restriction of proliferation.
Johansson K; Gagnon JD; Zhou S; Fassett MS; Schroeder AW; Kageyama R; Bautista RA; Pham H; Woodruff PG; Ansel KM
bioRxiv; 2023 Mar; ():. PubMed ID: 36993421
[TBL] [Abstract][Full Text] [Related]
3. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
4. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells.
Mittag D; Scholzen A; Varese N; Baxter L; Paukovics G; Harrison LC; Rolland JM; O'Hehir RE
J Immunol; 2010 May; 184(9):4708-16. PubMed ID: 20308632
[TBL] [Abstract][Full Text] [Related]
5. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
6. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
7. Expansion of human regulatory T-cells from patients with type 1 diabetes.
Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
[TBL] [Abstract][Full Text] [Related]
8. Human CD8
Rouas R; Merimi M; Najar M; El Zein N; Fayyad-Kazan M; Berehab M; Agha D; Bron D; Burny A; Rachidi W; Badran B; Lewalle P; Fayyad-Kazan H
J Cell Physiol; 2019 Aug; 234(10):17459-17472. PubMed ID: 30805923
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.
Kohlhaas S; Garden OA; Scudamore C; Turner M; Okkenhaug K; Vigorito E
J Immunol; 2009 Mar; 182(5):2578-82. PubMed ID: 19234151
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-155 is required for expansion of regulatory T cells to mediate robust pregnancy tolerance in mice.
Schjenken JE; Moldenhauer LM; Zhang B; Care AS; Groome HM; Chan HY; Hope CM; Barry SC; Robertson SA
Mucosal Immunol; 2020 Jul; 13(4):609-625. PubMed ID: 31988469
[TBL] [Abstract][Full Text] [Related]
11. CD226 deficiency on regulatory T cells aggravates renal fibrosis via up-regulation of Th2 cytokines through miR-340.
Mu Y; Zhang J; Liu Y; Ma J; Jiang D; Zhang X; Yi X; Cheng K; Shen S; Yang Y; Zhuang R; Zhang Y
J Leukoc Biol; 2020 Apr; 107(4):573-587. PubMed ID: 31802539
[TBL] [Abstract][Full Text] [Related]
12. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
[TBL] [Abstract][Full Text] [Related]
13. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
[TBL] [Abstract][Full Text] [Related]
14. Providence of the CD25
Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs are implicated in the suppression of CD4+CD25− conventional T cell proliferation by CD4+CD25+ regulatory T cells.
Zhou S; Dong X; Zhang C; Chen X; Zhu J; Li W; Song X; Xu Z; Zhang W; Yang X; Li Y; Liu F; Sun C
Mol Immunol; 2015 Feb; 63(2):464-72. PubMed ID: 25457879
[TBL] [Abstract][Full Text] [Related]
16. Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function.
Ma X; Cao L; Raneri M; Wang H; Cao Q; Zhao Y; Bediaga NG; Naselli G; Harrison LC; Hawthorne WJ; Hu M; Yi S; O'Connell PJ
JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37874660
[TBL] [Abstract][Full Text] [Related]
17. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis patients have reduced resting and increased activated CD4
Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ
Sci Rep; 2021 May; 11(1):10476. PubMed ID: 34006899
[TBL] [Abstract][Full Text] [Related]
19. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
20. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
